Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
28th August 2017
What is Myopia Management? Myopia Management is the process of reducing the progression of short-sightedness (Myopia) in children. We do not know exactly what causes children to become more short-s...Read more
10th August 2017
Pre-school vision screening should not negate the need for a comprehensive pre-school eye examination. In Scotland, we are fortunate that all children receive a Pre-School Orthoptic Vision Screenin...Read more